Meta-Analysis Appraising High Clopidogrel Loading in Patients Undergoing Percutaneous Coronary Intervention † † Conflicts of interest: Dr. Angiolillo is a consultant and on the speaker’s bureau for Bristol Myers Squibb, New York, New York, and Sanofi-Aventis, Paris, France. Dr. Biondi-Zoccai has consulted for Boston Scientific, Natick, Massachusetts, and Cordis, Miami, Florida, and received lecture fees from Bristol Myers Squibb. Dr. Montalescot has been a consultant for and/or received research grants from Sanofi-Aventis.
Titel:
Meta-Analysis Appraising High Clopidogrel Loading in Patients Undergoing Percutaneous Coronary Intervention † † Conflicts of interest: Dr. Angiolillo is a consultant and on the speaker’s bureau for Bristol Myers Squibb, New York, New York, and Sanofi-Aventis, Paris, France. Dr. Biondi-Zoccai has consulted for Boston Scientific, Natick, Massachusetts, and Cordis, Miami, Florida, and received lecture fees from Bristol Myers Squibb. Dr. Montalescot has been a consultant for and/or received research grants from Sanofi-Aventis.
Auteur:
Lotrionte, Marzia Biondi-Zoccai, Giuseppe G.L. Agostoni, Pierfrancesco Abbate, Antonio Angiolillo, Dominick J. Valgimigli, Marco Moretti, Claudio Meliga, Emanuele Cuisset, Thomas Alessi, Marie-Christine Montalescot, Gilles Collet, Jean-Philippe Di Sciascio, Germano Waksman, Ron Testa, Luca Sangiorgi, Giuseppe Laudito, Antonio Trevi, Gian P. Sheiban, Imad